The name CJC-1295 without DAC is commonly used for modified GRF 1–29, a shorter-acting growth hormone-releasing hormone analogue. Research interests include pulsatile endocrine responses and GHRH receptor activity.
Key research interests
• GHRH receptor signaling
• Pulsatile growth hormone responses
• Sequence and exposure characterization
Not for human or veterinary use
The name CJC-1295 without DAC is commonly used for modified GRF 1–29, a shorter-acting growth hormone-releasing hormone analogue. Research interests include pulsatile endocrine responses and GHRH receptor activity.
Key research interests
• GHRH receptor signaling
• Pulsatile growth hormone responses
• Sequence and exposure characterization
Not for human or veterinary use